ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: (617) 551-8200
EIN: 770602661
State Location: MA
- Nasdaq:ALNY
Form: 8-K
Filing Date: 27 May 2026Report Date: 20 May 2026
Accepted: 27 May 2026 02:30 p.m.
Accession Number: 0001628280-26-038499
File Number: 001-36407
Film Number: 261026646
Items: 5.02,5.07
Documents
Primary Document: 8-K
Accepted: 27 May 2026 02:30 p.m.
0001628280-26-038499-index-headers.html
Last Modified: 27 May 2026 02:30 p.m.
0001628280-26-038499-index.html
Last Modified: 27 May 2026 02:30 p.m.
0001628280-26-038499.txt
Last Modified: 27 May 2026 02:30 p.m.
0001628280-26-038499-xbrl.zip
Last Modified: 27 May 2026 02:30 p.m.
alny-20260520.xsd
Last Modified: 27 May 2026 02:30 p.m.
alny-20260520_htm.xml
Last Modified: 27 May 2026 02:30 p.m.
alny-20260520_lab.xml
Last Modified: 27 May 2026 02:30 p.m.
alny-20260520_pre.xml
Last Modified: 27 May 2026 02:30 p.m.
FilingSummary.xml
Last Modified: 27 May 2026 02:30 p.m.
MetaLinks.json
Last Modified: 27 May 2026 02:30 p.m.
R1.htm
Last Modified: 27 May 2026 02:30 p.m.
report.css
Last Modified: 27 May 2026 02:30 p.m.
Show.js
Last Modified: 27 May 2026 02:30 p.m.